EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines

Mukaddes Sena Cinar, Trevor M Adams, Fathima Zahra Nawaz, Elif S Demir, Mariye Erol Demirturk, Aidan P Keelaghan, Shaima M Nazaar, Blaine R Roberts, Ahmet Ozdilek, Fikri Y Avci

Journal of Biological Chemistry · 2026-05 · 302 (5) · 111423

DOI: 10.1016/j.jbc.2026.111423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-05. Verfasst von Mukaddes Sena Cinar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Antigens, Bacterial, Immune Evasion, Mycobacterium tuberculosis, Vaccines, DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid vaccines (DNA and mRNA) induce immunity by driving in situ antigen expression in host cells. For nonviral pathogens, however, host expression can impose post-translational modifications absent from the native microbial antigen. Tuberculosis remains a leading cause of infectious mortality, and nucleic acid vaccines targeting the Mycobacterium tuberculosis antigen 85 (Ag85) complex did not confer protective efficacy in clinical trials. We hypothesized that host-derived N-glycosylation of Ag85 immunogens expressed in mammalian cells compromises immune recognition. Here, we define structural, biochemical, and immunological mechanisms by which host-imposed N-glycosylation remodels a bacterial antigen expressed in mammalian cells. We show that Ag85B expressed in human Expi293 cells is microheterogeneously N-glycosylated at four canonical sequons (N52, N224, N234, and N280) with predominantly complex, highly fucosylated, and frequently sialylated glycans. Molecular dynamics simulations indicate that these glycans occupy substantial conformational space and reduce solvent and antibody-accessible surface area, occluding multiple established B-cell and T-cell epitope regions. Consistent with glycan-mediated shielding, mammalian-expressed Ag85B shows markedly reduced binding to an Ag85-complex monoclonal antibody by competitive ELISA and biolayer interferometry, and sialylated glycans enable Siglec-9 binding that is abrogated by sialidase treatment. Together, these findings define the structural and biochemical mechanisms by which host glycosylation can remodel bacterial vaccine antigens, supporting glycosylation-aware immunogen engineering as a design principle for nucleic acid vaccines targeting nonviral pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, BacterialImmune EvasionMycobacterium tuberculosisVaccines, DNAAcyltransferasesGlycosylationHumansMolecular Dynamics Simulation

Stichwörter der Autor:innen

Mycobacterium tuberculosisantigenicityglycomicsglycopeptidomicsimmunogenicitymRNA vaccinesmammalian N-glycosylationmolecular dynamicsnucleic acid vaccines

Substanzen

Antigens, BacterialVaccines, DNAAcyltransferases

Autor:innen und Institutionen

  • Department of Biochemistry, Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Biochemistry, Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: favci@emory.edu.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research

Zitieren

APA

Cinar, M. S., Adams, T. M., Nawaz, F. Z., Demir, E. S., Erol Demirturk, M., Keelaghan, A. P., Nazaar, S. M., Roberts, B. R., Ozdilek, A., & Avci, F. Y. (2026). Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines. Journal of Biological Chemistry, 302(5), 111423. https://doi.org/10.1016/j.jbc.2026.111423

Vancouver

Cinar MS, Adams TM, Nawaz FZ, Demir ES, Erol Demirturk M, Keelaghan AP, et al. Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines. Journal of Biological Chemistry. 2026;302(5):111423. doi:10.1016/j.jbc.2026.111423

BibTeX
@article{Cinar2026,
  author = {Cinar, Mukaddes Sena and Adams, Trevor M and Nawaz, Fathima Zahra and Demir, Elif S and Erol Demirturk, Mariye and Keelaghan, Aidan P and Nazaar, Shaima M and Roberts, Blaine R and Ozdilek, Ahmet and Avci, Fikri Y},
  title = {Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  volume = {302},
  number = {5},
  pages = {111423},
  doi = {10.1016/j.jbc.2026.111423}
}
Kostenlos starten →